Synonyms: A-50912 | Abbott 50192 | Bestron® | Cefmax® | SCE-1365
cefmenoxime is an approved drug (FDA (1987))
Compound class:
Synthetic organic
Comment: Cefmenoxime is a semisynthetic, third generation cephalosporin and belongs to the β-lactam class of antibacterial compounds [1]. It has broad-spectrum activity against both Gram-positive and Gram-negative bacteria and is resistant to hydrolysis by β-lactamases.
|
|
Bioactivity Comments |
Cefmenoxime MIC90 values have been determined for a range of clinical isolates including: Staphylococcus aureus (1.56 μg/ml), Streptococcus pyogenes (0.013 μg/ml), Haemophilus influenzae (0.025 μg/ml), and Pseudomonas aeruginosa (25 μg/ml) [1]. |